Medications for Bronchiolitis Obliterans Syndrome
3 results
Imbruvica (ibrutinib)
(Ibrutinib)Pharmacyclics LLC
Usage: IMBRUVICA is indicated for treating adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia (WM), and chronic graft-versus-host disease (cGVHD) in patients aged 1 year and older after failure of one or more systemic therapy lines.
Jakafi (ruxolitinib)
(ruxolitinib)Incyte Corporation
Usage: Jakafi is indicated for treating intermediate or high-risk myelofibrosis, polycythemia vera in adults intolerant to hydroxyurea, and steroid-refractory acute graft-versus-host disease in patients aged 12 and older. It also treats chronic graft-versus-host disease after failure of one or two prior systemic therapies in the same age group.
Rezurock (belumosudil)
(belumosudil)Kadmon Pharmaceuticals, LLC
Usage: REZUROCK is indicated for treating chronic graft-versus-host disease (GVHD) in adults and pediatric patients aged 12 and older after failure of at least two prior systemic therapies.